07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
On June 19, 2019, the New York State Legislature passed Senate Bill S.6577, which upon Governor Cuom...
Read More >
HEADLINES - Buyouts and M&A secured a combined €75.4 billion of loan issuance in 2019 - Proceeds ...
Read More >
30 June - The Financial Conduct Authority (“FCA”) announced that the deadline for solo-regulated...
Read More >
On February 11, 2020, the Equal Employment Opportunity Commission (EEOC) filed a complaint in Connec...
Read More >
HSR Act Thresholds - The Federal Trade Commission ("FTC") recently announced the revised transactio...
Read More >
Connecticut’s trend of liberal, policyholder-oriented insurance coverage decisions continued apace ...
Read More >